Emergent Biosolutions
EBS
EBS
214 hedge funds and large institutions have $1.22B invested in Emergent Biosolutions in 2016 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 84 increasing their positions, 76 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $1.29B → $1.22B (-$72.1M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
58% less call options, than puts
Call options by funds: $2.64M | Put options by funds: $6.25M
Holders
214
Holding in Top 10
2
Calls
$2.64M
Puts
$6.25M
Top Buyers
| 1 | +$24.5M | |
| 2 | +$14.4M | |
| 3 | +$11.1M | |
| 4 |
TA
Teachers Advisors
New York
|
+$8.13M |
| 5 |
State Street
Boston,
Massachusetts
|
+$7.56M |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$18.3M | |
| 3 | -$8.94M | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$6.17M |
| 5 |
FMA
Fiduciary Management Associates
Chicago,
Illinois
|
-$5.68M |